臨床研究③

[JP6-5] A survey of prescription at discharge for schizophrenia and depression focusing on medication type -From the EGUIDE prescription survey-

*Naoki Hashimoto¹, Norio Furukori², Naomi Hasegawa⁹, Hikaru Hori⁴, Hitoshi Iida⁴, Kayo Ichihashi⁵, Shusuke Numata³, Fumitoshi Kodaka⁸, Ryuji Furihata⁷, Ken Inada⁶, Ryota Hashimoto⁹ (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 3. Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan., 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan., 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan., 6. Department of Psychiatry, Kitasato University School of Medicine, 7. Agency for Student Support and Disability Resources, Kyoto University, 8. Department of Psychiatry, The Jikei University School of Medicine, 9. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.)